Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PENthis companyPenumbra, Inc.	$319.79	68.03×	8.48×	8.62×	54.19×	-128.8%	67.1%	13.5%	12.7%	12.4%	9.9%	1.4%	0.15×	0.15×	144.35×	6.64×	0.0%	5	19.11	3	B
ABTAbbott Laboratories	$109.23	33.5×	4.2×	4.94×	18.91×	22.3%	55.5%	18.2%	14.7%	12.5%	8.4%	3.4%	0.29×	0.55×	23.6×	1.58×	1.9%	6	3.29	2	C
ANGOAngioDynamics, Inc.	$12.07	-12.4×	2.65×	1.42×	818×	-138.7%	54.6%	-12.5%	-11.5%	-21.5%	-20.7%	0.1%	0×	-110.38×	-133.54×	2.19×	0.0%	5	2.38	2	C+
BSXBoston Scientific Corporation	$43.49	48.65×	5.82×	7.03×	29.7×	100.4%	69.0%	19.8%	14.4%	11.9%	8.8%	2.6%	0.51×	2.03×	11.38×	1.62×	0.0%	6	2.89	2	C+
EWEdwards Lifesciences Corporation	$103.53	46.33×	4.82×	8.22×	33.31×	-37.2%	78.1%	27.0%	17.7%	10.4%	11.4%	2.7%	0.07×	-1.56×	0×	3.72×	0.0%	6	12.89	3	B
ISRGIntuitive Surgical, Inc.	$456.17	70.8×	11.34×	20.08×	49.91×	-72.6%	66.0%	29.3%	28.4%	16.0%	13.7%	1.2%	0.02×	-0.77×	0×	4.87×	0.0%	7	30.62	3	B
Peer median	—	46.33×	4.82×	7.03×	33.31×	-37.2%	66.0%	19.8%	14.7%	11.9%	8.8%	2.6%	0.07×	-0.77×	0×	2.19×	0.0%	6	3.29	2	—